Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 2.3300 |
| 開市 | 2.4300 |
| 買盤 | 2.3700 x 1500 |
| 賣出價 | 2.3900 x 100 |
| 今日波幅 | 2.3200 - 2.4400 |
| 52 週波幅 | 0.9200 - 3.7300 |
| 成交量 | |
| 平均成交量 | 2,806,566 |
| 市值 | 863.966M |
| Beta 值 (5 年，每月) | 1.36 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.8300 |
| 業績公佈日 | 2024年8月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 6.25 |
ZacksBiotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
Cassava Sciences, Inc. (SAVA) and Lexeo Therapeutics (LXEO) are in the spotlight following updates.
ZacksFDA Accepts Lexicon's (LXRX) NDA for Type I Diabetes Drug
The FDA accepts Lexicon's (LXRX) resubmission seeking approval for sotagliflozin to treat adults with type 1 diabetes. A final decision is expected by Dec 20.
ZacksStrength Seen in IDEAYA Biosciences (IDYA): Can Its 15.3% Jump Turn into More Strength?
IDEAYA Biosciences (IDYA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
